{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:36:39Z","timestamp":1759451799980,"version":"build-2065373602"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Herz"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00059-025-05329-7","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T13:24:25Z","timestamp":1756387465000},"page":"326-336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interdisziplin\u00e4re Behandlung der Trikuspidalklappeninsuffizienz","Interdisciplinary management of tricuspid valve regurgitation"],"prefix":"10.1007","volume":"50","author":[{"given":"Marc Adrian","family":"Rogmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Zancanaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrik","family":"Treede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Lurz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl-Patrik","family":"Kresoja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"5329_CR1","doi-asserted-by":"publisher","DOI":"10.23736\/S0021-9509.18.10468-X","author":"A Dhoble","year":"2019","unstructured":"Dhoble\u00a0A, Zhao\u00a0Y, Vejpongsa\u00a0P et\u00a0al (2019) National 10-year trends and outcomes of isolated and concomitant tricuspid valve surgery. J\u00a0Cardiovasc Surg (torino). https:\/\/doi.org\/10.23736\/S0021-9509.18.10468-X","journal-title":"J Cardiovasc Surg (torino)"},{"key":"5329_CR2","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.1093\/eurheartj\/ehaa643","volume":"41","author":"J Dreyfus","year":"2020","unstructured":"Dreyfus\u00a0J, Flagiello\u00a0M, Bazire\u00a0B et\u00a0al (2020) Isolated tricuspid valve surgery: impact of aetiology and clinical presentation on outcomes. Eur Heart\u00a0J 41:4304\u20134317. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa643","journal-title":"Eur Heart J"},{"key":"5329_CR3","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jacc.2019.04.028","volume":"74","author":"AL Axtell","year":"2019","unstructured":"Axtell\u00a0AL, Bhambhani\u00a0V, Moonsamy\u00a0P et\u00a0al (2019) Surgery Does Not Improve Survival in Patients With Isolated Severe Tricuspid Regurgitation. J\u00a0Am Coll Cardiol 74:715\u2013725. https:\/\/doi.org\/10.1016\/j.jacc.2019.04.028","journal-title":"J Am Coll Cardiol"},{"key":"5329_CR4","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s12181-024-00715-7","volume":"18","author":"S Ensminger","year":"2024","unstructured":"Ensminger\u00a0S, Thiele\u00a0H, Falk\u00a0V, Rudolph\u00a0V (2024) Der Deutsche Herzbericht \u2013 Update 2024 \u2013 Eine Zusammenfassung der wichtigsten Erkenntnisse. Kardiologie 18:476\u2013484. https:\/\/doi.org\/10.1007\/s12181-024-00715-7","journal-title":"Kardiologie"},{"key":"5329_CR5","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/ejhf.2858","volume":"25","author":"G Heitzinger","year":"2023","unstructured":"Heitzinger\u00a0G, Pavo\u00a0N, Koschatko\u00a0S et\u00a0al (2023) Contemporary insights into the epidemiology, impact and treatment of secondary tricuspid regurgitation across the heart failure spectrum. Eur J Heart Fail 25:857\u2013867. https:\/\/doi.org\/10.1002\/ejhf.2858","journal-title":"Eur J Heart Fail"},{"key":"5329_CR6","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/ejhf.3195","volume":"26","author":"K Kresoja","year":"2024","unstructured":"Kresoja\u00a0K, Rosch\u00a0S, Sch\u00f6ber\u00a0AR et\u00a0al (2024) Implications of tricuspid regurgitation and right ventricular volume overload in patients with heart failure with preserved ejection fraction. Eur J Heart Fail 26:1025\u20131035. https:\/\/doi.org\/10.1002\/ejhf.3195","journal-title":"Eur J Heart Fail"},{"key":"5329_CR7","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1056\/NEJMra2216709","volume":"388","author":"RT Hahn","year":"2023","unstructured":"Hahn\u00a0RT (2023) Tricuspid Regurgitation. N\u00a0Engl J Med 388:1876\u20131891. https:\/\/doi.org\/10.1056\/NEJMra2216709","journal-title":"N Engl J Med"},{"key":"5329_CR8","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/eurheartj\/ehae733","volume":"46","author":"P Lurz","year":"2025","unstructured":"Lurz\u00a0P, Zancanaro\u00a0E, Kresoja\u00a0K\u2011P (2025) Personalized management of tricuspid valve regurgitation. Eur Heart\u00a0J 46:882\u2013884. https:\/\/doi.org\/10.1093\/eurheartj\/ehae733","journal-title":"Eur Heart J"},{"key":"5329_CR9","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jcmg.2018.06.014","volume":"12","author":"Y Topilsky","year":"2019","unstructured":"Topilsky\u00a0Y, Maltais\u00a0S, Medina Inojosa\u00a0J et\u00a0al (2019) Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging 12:433\u2013442. https:\/\/doi.org\/10.1016\/j.jcmg.2018.06.014","journal-title":"JACC Cardiovasc Imaging"},{"key":"5329_CR10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1093\/eurheartj\/ehy641","volume":"40","author":"N Wang","year":"2019","unstructured":"Wang\u00a0N, Fulcher\u00a0J, Abeysuriya\u00a0N et\u00a0al (2019) Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a\u00a0systematic review and meta-analysis. Eur Heart\u00a0J 40:476\u2013484. https:\/\/doi.org\/10.1093\/eurheartj\/ehy641","journal-title":"Eur Heart J"},{"key":"5329_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-025-02662-z","author":"J Rodr\u00edguez-Capit\u00e1n","year":"2025","unstructured":"Rodr\u00edguez-Capit\u00e1n\u00a0J, M\u00e1rquez-Camas\u00a0P, Carmona-Carmona\u00a0J et\u00a0al (2025) Etiology of tricuspid regurgitation and mortality: a\u00a0multicenter cohort study. Clin Res Cardiol. https:\/\/doi.org\/10.1007\/s00392-025-02662-z","journal-title":"Clin Res Cardiol"},{"key":"5329_CR12","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1016\/j.jacc.2023.02.049","volume":"81","author":"SK Kodali","year":"2023","unstructured":"Kodali\u00a0SK, Hahn\u00a0RT, Davidson\u00a0CJ et\u00a0al (2023) 1\u2011Year Outcomes of Transcatheter Tricuspid Valve Repair. J\u00a0Am Coll Cardiol 81:1766\u20131776. https:\/\/doi.org\/10.1016\/j.jacc.2023.02.049","journal-title":"J Am Coll Cardiol"},{"key":"5329_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jacc.2020.11.038","volume":"77","author":"P Lurz","year":"2021","unstructured":"Lurz\u00a0P, Von Bardeleben\u00a0RS, Weber\u00a0M et\u00a0al (2021) Transcatheter Edge-to-Edge Repair for Treatment of Tricuspid Regurgitation. J\u00a0Am Coll Cardiol 77:229\u2013239. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.038","journal-title":"J Am Coll Cardiol"},{"key":"5329_CR14","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1016\/j.jcin.2019.09.046","volume":"12","author":"NP Fam","year":"2019","unstructured":"Fam\u00a0NP, Braun\u00a0D, Von Bardeleben\u00a0RS et\u00a0al (2019) Compassionate Use of the PASCAL Transcatheter Valve Repair System for Severe Tricuspid Regurgitation. JACC Cardiovasc Interv 12:2488\u20132495. https:\/\/doi.org\/10.1016\/j.jcin.2019.09.046","journal-title":"JACC Cardiovasc Interv"},{"key":"5329_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1161\/CIRCULATIONAHA.125.074536","volume":"074536","author":"S Kar","year":"2025","unstructured":"Kar\u00a0S, Makkar\u00a0RR, Whisenant\u00a0BK et\u00a0al (2025) Two-year Outcomes of Transcatheter Edge-to-edge Repair for Severe Tricuspid Regurgitation: The TRILUMINATE Pivotal Randomized Trial. Circ Circ 074536:125. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.125.074536","journal-title":"Circ Circ"},{"key":"5329_CR16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jchf.2019.12.006","volume":"8","author":"M Orban","year":"2020","unstructured":"Orban\u00a0M, Rommel\u00a0K\u2011P, Ho\u00a0EC et\u00a0al (2020) Transcatheter Edge-to-Edge Tricuspid Repair for Severe Tricuspid Regurgitation Reduces Hospitalizations for Heart Failure. JACC Heart Fail 8:265\u2013276. https:\/\/doi.org\/10.1016\/j.jchf.2019.12.006","journal-title":"JACC Heart Fail"},{"key":"5329_CR17","doi-asserted-by":"publisher","unstructured":"Tomasoni D, Adamo M, Hausleiter J et\u00a0al Heart failure hospitalizations and clinical outcomes in patients undergoing tricuspid transcatheter edge-to-edge repair: Insights from EuroTR. Eur J Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.3757","DOI":"10.1002\/ejhf.3757"},{"key":"5329_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001232","author":"LJ Davidson","year":"2024","unstructured":"Davidson\u00a0LJ, Tang\u00a0GHL, Ho\u00a0EC et\u00a0al (2024) The Tricuspid Valve: A\u00a0Review of Pathology, Imaging, and Current Treatment Options: A\u00a0Scientific Statement From the American Heart Association. Circulation. https:\/\/doi.org\/10.1161\/CIR.0000000000001232","journal-title":"Circulation"},{"key":"5329_CR19","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jacc.2024.10.068","volume":"85","author":"MG Wild","year":"2025","unstructured":"Wild\u00a0MG, Stolz\u00a0L, Rosch\u00a0S et\u00a0al (2025) Transcatheter Valve Repair for Tricuspid Regurgitation. J\u00a0Am Coll Cardiol 85:220\u2013231. https:\/\/doi.org\/10.1016\/j.jacc.2024.10.068","journal-title":"J Am Coll Cardiol"},{"key":"5329_CR20","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jcmg.2024.04.008","volume":"17","author":"M Ger\u00e7ek","year":"2024","unstructured":"Ger\u00e7ek\u00a0M, Narang\u00a0A, K\u00f6rber\u00a0MI et\u00a0al (2024) GLIDE Score. JACC Cardiovasc Imaging 17:729\u2013742. https:\/\/doi.org\/10.1016\/j.jcmg.2024.04.008","journal-title":"JACC Cardiovasc Imaging"},{"key":"5329_CR21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJMoa2401918","volume":"392","author":"RT Hahn","year":"2025","unstructured":"Hahn\u00a0RT, Makkar\u00a0R, Thourani\u00a0VH et\u00a0al (2025) Transcatheter Valve Replacement in Severe Tricuspid Regurgitation. N\u00a0Engl J Med 392:115\u2013126. https:\/\/doi.org\/10.1056\/NEJMoa2401918","journal-title":"N Engl J Med"},{"key":"5329_CR22","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.athoracsur.2016.06.004","volume":"103","author":"V Badhwar","year":"2017","unstructured":"Badhwar\u00a0V, Rankin\u00a0JS, He\u00a0M et\u00a0al (2017) Performing Concomitant Tricuspid Valve Repair at the Time of Mitral Valve Operations Is Not Associated With Increased Operative Mortality. Ann Thorac Surg 103:587\u2013593. https:\/\/doi.org\/10.1016\/j.athoracsur.2016.06.004","journal-title":"Ann Thorac Surg"},{"key":"5329_CR23","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.jtcvs.2010.05.050","volume":"141","author":"NR Van De Veire","year":"2011","unstructured":"Van De Veire\u00a0NR, Braun\u00a0J, Delgado\u00a0V et\u00a0al (2011) Tricuspid annuloplasty prevents right ventricular dilatation and progression of tricuspid regurgitation in patients with tricuspid annular dilatation undergoing mitral valve repair. J\u00a0Thorac Cardiovasc Surg 141:1431\u20131439. https:\/\/doi.org\/10.1016\/j.jtcvs.2010.05.050","journal-title":"J Thorac Cardiovasc Surg"},{"key":"5329_CR24","doi-asserted-by":"publisher","first-page":"e2428032","DOI":"10.1001\/jamanetworkopen.2024.28032","volume":"7","author":"N Kagiyama","year":"2024","unstructured":"Kagiyama\u00a0N, Kaneko\u00a0T, Amano\u00a0M et\u00a0al (2024) Clinical Outcomes of Mitral Valve Surgery in Atrial Functional Mitral Regurgitation in the REVEAL-AFMR Registry. Jama Netw Open 7:e2428032. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.28032","journal-title":"Jama Netw Open"},{"key":"5329_CR25","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.rec.2022.05.006","volume":"75","author":"A Vahanian","year":"2022","unstructured":"Vahanian\u00a0A, Beyersdorf\u00a0F, Praz\u00a0F et\u00a0al (2022) 2021 ESC\/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Rev Esp Cardiol Engl Ed 75:524. https:\/\/doi.org\/10.1016\/j.rec.2022.05.006","journal-title":"Rev Esp Cardiol Engl Ed"},{"key":"5329_CR26","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.jtcvs.2021.11.102","volume":"166","author":"G F\u00e4rber","year":"2023","unstructured":"F\u00e4rber\u00a0G, Marx\u00a0J, Scherag\u00a0A et\u00a0al (2023) Risk stratification for isolated tricuspid valve surgery assisted using the Model for End-Stage Liver Disease score. J\u00a0Thorac Cardiovasc Surg 166:1433\u20131441.e1. https:\/\/doi.org\/10.1016\/j.jtcvs.2021.11.102","journal-title":"J Thorac Cardiovasc Surg"},{"key":"5329_CR27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/jocs.16098","volume":"37","author":"TKM Wang","year":"2022","unstructured":"Wang\u00a0TKM, Akyuz\u00a0K, Kirincich\u00a0J et\u00a0al (2022) Comparison of risk scores for predicting outcomes after isolated tricuspid valve surgery. J\u00a0Card Surg 37:126\u2013134. https:\/\/doi.org\/10.1111\/jocs.16098","journal-title":"J Card Surg"},{"key":"5329_CR28","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.athoracsur.2018.12.011","volume":"107","author":"RB Hawkins","year":"2019","unstructured":"Hawkins\u00a0RB, Young\u00a0BAC, Mehaffey\u00a0JH et\u00a0al (2019) Model for End-Stage Liver Disease Score Independently Predicts Mortality in Cardiac Surgery. Ann Thorac Surg 107:1713\u20131719. https:\/\/doi.org\/10.1016\/j.athoracsur.2018.12.011","journal-title":"Ann Thorac Surg"},{"key":"5329_CR29","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1093\/icvts\/ivt014","volume":"16","author":"K Tsuda","year":"2013","unstructured":"Tsuda\u00a0K, Koide\u00a0M, Kunii\u00a0Y et\u00a0al (2013) Simplified model for end-stage liver disease score predicts mortality for tricuspid valve surgery. Interact CardioVasc Thorac Surg 16:630\u2013635. https:\/\/doi.org\/10.1093\/icvts\/ivt014","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"5329_CR30","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jcin.2024.10.034","volume":"18","author":"F Schlotter","year":"2025","unstructured":"Schlotter\u00a0F, Stolz\u00a0L, Kresoja\u00a0K\u2011P et\u00a0al (2025) Tricuspid Regurgitation Disease Stages and Treatment Outcomes After Transcatheter Tricuspid Valve Repair. JACC Cardiovasc Interv 18:339\u2013348. https:\/\/doi.org\/10.1016\/j.jcin.2024.10.034","journal-title":"JACC Cardiovasc Interv"},{"key":"5329_CR31","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/eurheartj\/ehad585","volume":"45","author":"J Dreyfus","year":"2024","unstructured":"Dreyfus\u00a0J, Galloo\u00a0X, Taramasso\u00a0M et\u00a0al (2024) TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation. Eur Heart\u00a0J 45:586\u2013597. https:\/\/doi.org\/10.1093\/eurheartj\/ehad585","journal-title":"Eur Heart J"},{"key":"5329_CR32","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/jcdd10030118","volume":"10","author":"J-A Sauv\u00e9","year":"2023","unstructured":"Sauv\u00e9\u00a0J\u2011A, Wu\u00a0Y\u2011S, Ghatanatti\u00a0R, Zacharias\u00a0J (2023) Minimal Access Tricuspid Valve Surgery. J\u00a0Cardiovasc Dev Dis 10:118. https:\/\/doi.org\/10.3390\/jcdd10030118","journal-title":"J Cardiovasc Dev Dis"},{"key":"5329_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13019-020-01192-1","author":"S Lu","year":"2020","unstructured":"Lu\u00a0S, Song\u00a0K, Yao\u00a0W et\u00a0al (2020) Simplified, minimally invasive, beating-heart technique for redo isolated tricuspid valve surgery. J\u00a0Cardiothorac Surg. https:\/\/doi.org\/10.1186\/s13019-020-01192-1","journal-title":"J Cardiothorac Surg"},{"key":"5329_CR34","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1093\/eurheartj\/ehab679","volume":"43","author":"J Dreyfus","year":"2022","unstructured":"Dreyfus\u00a0J, Audureau\u00a0E, Bohbot\u00a0Y et\u00a0al (2022) TRI-SCORE: a\u00a0new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery. Eur Heart\u00a0J 43:654\u2013662. https:\/\/doi.org\/10.1093\/eurheartj\/ehab679","journal-title":"Eur Heart J"},{"key":"5329_CR35","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.122.012888","author":"RS Von Bardeleben","year":"2023","unstructured":"Von Bardeleben\u00a0RS, Lurz\u00a0P, Sorajja\u00a0P et\u00a0al (2023) Two-Year Outcomes for Tricuspid Repair With a\u00a0Transcatheter Edge-to-Edge Valve Repair From the Transatlantic TRILUMINATE Trial. Circ Cardiovasc Interv. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.122.012888","journal-title":"Circ Cardiovasc Interv"},{"key":"5329_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2025.03.003","author":"RT Hahn","year":"2025","unstructured":"Hahn\u00a0RT, Badano\u00a0L, Praz\u00a0F et\u00a0al (2025) The Last Decade in Tricuspid Regurgitation. JACC Cardiovasc Imaging. https:\/\/doi.org\/10.1016\/j.jcmg.2025.03.003","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Herz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-025-05329-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00059-025-05329-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00059-025-05329-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T08:50:00Z","timestamp":1759395000000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00059-025-05329-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["5329"],"URL":"https:\/\/doi.org\/10.1007\/s00059-025-05329-7","relation":{},"ISSN":["0340-9937","1615-6692"],"issn-type":[{"type":"print","value":"0340-9937"},{"type":"electronic","value":"1615-6692"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"25 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Hiermit erkl\u00e4ren die unterzeichnenden Autoren im Zusammenhang mit dem eingereichten Manuskript folgenden Interessenkonfliktstatus gem\u00e4\u00df den Vorgaben der Zeitschrift Herz: M.A.\u00a0Rogmann erkl\u00e4rt, dass keine Beziehung zu gewinnorientierten oder nicht gewinnorientierten Organisationen, die im Zusammenhang mit dem Inhalt des Manuskripts stehen, besteht. E.\u00a0Zancanaro erhielt Honorare von Edwards Lifesciences. H.\u00a0Treede gibt an, dass kein Interessenkonflikt besteht. P.\u00a0Lurz erhielt Forschungsf\u00f6rderungen und institutionelle Zuwendungen von Abbott Vascular, Edwards Lifesciences und ReCor, Honorare von Edwards Lifesciences, Abbott Medical, Innoventric, ReCor und Boehringer Ingelheim sowie Aktienoptionen bei Innoventric. K.-P.\u00a0Kresoja ist in beratender Funktion f\u00fcr Edwards Lifesciences t\u00e4tig.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}